These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16109585)

  • 1. Effects of MPEP on expression of food-, MDMA- or amphetamine-conditioned place preference in rats.
    Herzig V; Capuani EM; Kovar KA; Schmidt WJ
    Addict Biol; 2005 Sep; 10(3):243-9. PubMed ID: 16109585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine.
    Herzig V; Schmidt WJ
    Neuropharmacology; 2004 Dec; 47(7):973-84. PubMed ID: 15555632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse.
    McGeehan AJ; Olive MF
    Synapse; 2003 Mar; 47(3):240-2. PubMed ID: 12494407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats.
    Rutten K; Van Der Kam EL; De Vry J; Bruckmann W; Tzschentke TM
    Addict Biol; 2011 Jan; 16(1):108-15. PubMed ID: 20579001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist.
    Popik P; Wróbel M
    Neuropharmacology; 2002 Dec; 43(8):1210-7. PubMed ID: 12527470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates ketamine and heroin reward as assessed by acquisition, extinction, and reinstatement of conditioned place preference in the rat.
    van der Kam EL; De Vry J; Tzschentke TM
    Eur J Pharmacol; 2009 Mar; 606(1-3):94-101. PubMed ID: 19210976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats.
    Meyer A; Mayerhofer A; Kovar KA; Schmidt WJ
    Neurosci Lett; 2002 Sep; 330(3):280-4. PubMed ID: 12270646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of d-govadine on conditioned place preference with d-amphetamine or food reward.
    Nesbit MO; Dias C; Phillips AG
    Behav Brain Res; 2017 Mar; 321():223-231. PubMed ID: 28062254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microinjection of the mGluR5 antagonist MTEP into the nucleus accumbens attenuates the acquisition but not expression of morphine-induced conditioned place preference in rats.
    Roohi N; Sarihi A; Shahidi S; Zarei M; Haghparast A
    Pharmacol Biochem Behav; 2014 Nov; 126():109-15. PubMed ID: 25284131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mGluR5 activation in the nucleus accumbens is not essential for sexual behavior or cross-sensitization of amphetamine responses by sexual experience.
    Pitchers KK; Di Sebastiano AR; Coolen LM
    Neuropharmacology; 2016 Aug; 107():122-130. PubMed ID: 26946431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of concurrent administration of +/-3,4-methylenedioxymethamphetamine and cocaine on conditioned place preference in the adult male rat.
    Diller AJ; Rocha A; Cardon AL; Valles R; Wellman PJ; Nation JR
    Pharmacol Biochem Behav; 2007 Dec; 88(2):165-70. PubMed ID: 17854876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the rat.
    Steiner MA; Lecourt H; Jenck F
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):417-32. PubMed ID: 22436395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3, 4-methylenedioxymethamphetamine (MDMA).
    Horan B; Gardner EL; Ashby CR
    Synapse; 2000 Feb; 35(2):160-2. PubMed ID: 10611642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mGluR5 antagonist MPEP suppresses the expression and reinstatement, but not the acquisition, of the ethanol-conditioned place preference in mice.
    Lee JY; Choe ES; Yang CH; Choi KH; Cheong JH; Jang CG; Seo JW; Yoon SS
    Pharmacol Biochem Behav; 2016 Jan; 140():33-8. PubMed ID: 26521964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of MDMA (ecstasy) on activity and cocaine conditioned place preference in adult and adolescent rats.
    Aberg M; Wade D; Wall E; Izenwasser S
    Neurotoxicol Teratol; 2007; 29(1):37-46. PubMed ID: 17049207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.
    Mannangatti P; Sundaramurthy S; Ramamoorthy S; Jayanthi LD
    Psychopharmacology (Berl); 2017 Feb; 234(4):695-705. PubMed ID: 28013351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of risperidone on the acquisition and reinstatement of the conditioned place preference induced by MDMA.
    Roger-Sánchez C; Rodríguez-Arias M; Miñarro J; Aguilar MA
    Brain Res Bull; 2013 Sep; 98():36-43. PubMed ID: 23892054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin and MDMA ('Ecstasy') enhance social reward in rats.
    Ramos L; Hicks C; Caminer A; Goodwin J; McGregor IS
    Psychopharmacology (Berl); 2015 Jul; 232(14):2631-41. PubMed ID: 25772337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of AMPA glutamate receptors in the conditioned rewarding effects of MDMA in mice.
    García-Pardo MP; Miñarro J; Aguilar MA
    Behav Brain Res; 2018 Jul; 347():57-60. PubMed ID: 29526785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse.
    Cole JC; Sumnall HR; O'Shea E; Marsden CA
    Psychopharmacology (Berl); 2003 Apr; 166(4):383-90. PubMed ID: 12601504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.